Clinical trial of arotinolol in the treatment of hypertension: Dippers vs. non-dippers

Hypertension Research

Volumn 24, Issue 5, 2001, Pages 605-610

  Wu, H ^a   Zhang, Y ^a,a   Huang, J ^a   Liu, G ^a   Sun, N ^a   Yu, Z ^a   Zhou, Y ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Ambulatory blood pressure monitoring; Arotinolol; Hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; AROTINOLOL; PLACEBO;

ADULT; AGED; BLOOD PRESSURE MONITORING; CALCULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG EFFICACY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MALE; MULTICENTER STUDY; SINGLE BLIND PROCEDURE; STATISTICAL ANALYSIS; SYSTOLIC BLOOD PRESSURE;

ADRENERGIC BETA-ANTAGONISTS; ADULT; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROPANOLAMINES; SINGLE-BLIND METHOD;

EID: 0035171625     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.24.605     Document Type: Conference Paper

References (16)

1. Blood pressure, cholesterol, and stroke in Eastern Asia
2. Ambulatory blood pressure monitoring: Dippers compared with non-dippers
3. Ambulatory blood pressure and prognosis
4. Application of ambulatory blood pressure monitoring in differentiating between anti-hypertensive agents
5. Reproducibility of ambulatory blood pressure monitoring in daily practice
6. Reproducibility and clinical value of nocturnal hypotension: Prospective evidence from the SAMPLE study: Study on Ambulatory Monitoring of Pressure and Lisinopril Evaluation
7. Effects of long-term therapy with arotinolol on blood pressure and renal function in hypertensive patients with chronic renal failure
8. Control of blood pressure and prevention of end-organ damage in patients with accelerated hypertension by combination with arotinolol and extended release nifedipine
9. Nifedipine and arotinolol in combination for accelerated-malignant hypertension: Results of one year follow-up
10. Autonomic nervous activity in elderly dipper and non-dipper patients with essential hypertension
11. Determinants of circadian blood pressure rhythm in essential hypertension
12. An overview of the pharmacodynamic properties and therapeutic potential of combined alpha- and beta-adrenoceptor antagonists
13. Influence of arotinolol hydrochloride on heart rate spectrum in hypertensive subjects
14. Effects of arotinolol on hemodynamics and adrenergically induced renin release and renal vasoconstriction
15. Effects of arotinolol, an alpha- and beta-adrenoceptor antagonist, on renin release from rat kidney cortical slices
16. Clinical significance of nocturnal blood pressure monitoring